Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 435

Results For "MED"

6233 News Found

Sanofi launches first-in-pharma Diversity, Equity & Inclusion Board
News | April 04, 2022

Sanofi launches first-in-pharma Diversity, Equity & Inclusion Board

Sanofi’s DE&I Board will include three of the most influential voices in the DE&I space as Board members appointed for 3 years: organizational psychologist & best-selling author John Amaechi, award-winning social entrepreneur Caroline Casey, and DE&I pioneer and renowned thought-leader Dr. Rohini Anand


FirstCure, a healthcare startup that simplifies surgeries
Startup | April 04, 2022

FirstCure, a healthcare startup that simplifies surgeries

It aims to make the state-of-the-art modern and safe surgical care, typically available in super-speciality hospitals of big cities, accessible, affordable, standardized and integrated


Intas and Axantia sign an exclusive agreement for Ranibizumab biosimilar
Biotech | April 04, 2022

Intas and Axantia sign an exclusive agreement for Ranibizumab biosimilar

Intas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA & the US


International Virchow Prize for Global Health launched
News | April 04, 2022

International Virchow Prize for Global Health launched

Highly prestigious award endowed with €500,000 to uphold the United Nations 2030 Agenda


Siemens Healthineers expands its manufacturing footprint under PLI scheme
Medical Device | April 04, 2022

Siemens Healthineers expands its manufacturing footprint under PLI scheme

The company inaugurated the new production line at the Bengaluru facility to manufacture Computed Tomography Scanners


Bayer to invest €1.3 billion for driving innovations in life sciences, agriculture segment
News | April 03, 2022

Bayer to invest €1.3 billion for driving innovations in life sciences, agriculture segment

Company announced that it is accelerating its investment in its Leaps by Bayer impact investment unit with more than 1.3 billion euros funding until end of 2024


WHO suspends supply of Covaxin under Covax facility
News | April 03, 2022

WHO suspends supply of Covaxin under Covax facility

WHO’s post EUA inspection found deficiencies in Good Manufacturing Practice at the facility


JBCPL buys Azmarda trademark for India at Rs 246 crore
News | April 03, 2022

JBCPL buys Azmarda trademark for India at Rs 246 crore

The brand Azmarda fits well with JBCPL's overall strategy of strengthening its presence in the cardiology segment in India.


Panacea Biotec appoints NK Juneja as additional director
People | April 03, 2022

Panacea Biotec appoints NK Juneja as additional director

He has done his Masters in Pharmacy (M. Pharm) and Post Graduate Diploma in Personnel Management & Industrial Relations


Jubilant Pharmova to acquire stake in Greencure
News | April 03, 2022

Jubilant Pharmova to acquire stake in Greencure

There is also a strong synergy between Jubilant and Greencure with respect to OTC portfolio which can be explored for R&D, online acceleration and offline distribution